Cluster Health & Mission Cancer Brokerage Event

28 Sept 2026 | Brussels, Belgium

Project cooperationUpdated on 11 September 2026

Expertise for HORIZON-HLTH-2027-01-CARE-02

Assoc. Prof. at Lithuanian university of health sciences

Kaunas, Lithuania

About

LSMU has extensive expertise in clinical medicine, pharmacotherapy, patient management, and personalized healthcare. The institution is interested in research addressing medication safety, optimization of treatment pathways, and reduction of adverse drug reactions in patients receiving multiple therapies. Clinical expertise across oncology and other chronic diseases provides valuable insights into complex treatment regimens and patient-centred care. LSMU can contribute to developing predictive models, risk stratification approaches, and evidence-based strategies supporting safer medication use. The institution seeks collaborations that promote personalized medicine and improved healthcare outcomes through multidisciplinary research and innovative digital solutions.

Topic

  • Healthcare innovations: HORIZON-HLTH-2027-01-CARE-02 Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications

Type

  • Partner seeks Consortium/Coordinator

Similar opportunities